Procedures treating peripheral artery disease to grow more than 70% by 2012

Jan. 21, 2008
January 21, 2008, Waltham, MA--According to a new research report from Millennium Research Group, minimally invasive procedures treating peripheral artery disease (PAD) will grow more than 70% by 2012, driven largely by the availability of successful treatment options including laser atherectomy and thrombectomy.

January 21, 2008, Waltham, MA--According to a new research report from Millennium Research Group, "US Markets for Plaque and Thrombus Management Devices 2008," minimally invasive procedures treating peripheral artery disease (PAD) will grow more than 70% by 2012, driven largely by the availability of successful treatment options including laser atherectomy and thrombectomy.

Today, only a small subset of patients actually receives an interventional treatment. Often times, PAD patients are treated with bypass surgery or worse, are forced to have limbs amputated because PAD is not caught in time. Less invasive procedures, such as atherectomy and thrombectomy, which remove plaque and thrombus matter that has formed along the vessel wall, are available if the disease is diagnosed before the critical end stage of its lifecycle.

Physician awareness of minimally invasive plaque and thrombus management procedures is expanding primarily due to research and clinical trials on a number of innovative devices. As a result, more physicians will adopt these new technologies, thus driving procedure growth and improving patient care.

"Today, physicians have more options for treating patients with PAD," says Bina Mistry, analyst at Millennium Research Group. "Specifically, we are noticing a large increase in the number of individuals receiving laser atherectomy and mechanical thrombectomy--two types of plaque and thrombus removal procedures--both in the US and in Europe."

The "Plaque and Thrombus Management Devices 2008" series includes coverage in the US and Europe for atherectomy, thrombectomy, chronic total occlusion crossing devices, and embolic protection devices. Coverage of industry competitors includes FoxHollow Technologies (ev3), Boston Scientific, Possis Medical, Spectranetics, and many others.

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!